Please login to the form below

gantenerumab

This page shows the latest gantenerumab news and features for those working in and with pharma, biotech and healthcare.

Roche starts new late-stage trials of Alzheimer’s candidate

Despite yet another failure for another amyloid-targeting drug for Alzheimer’s disease this week, Roche is pressing ahead with two large, phase III trials of its gantenerumab candidate. ... to gantenerumab as a potential new therapy for Alzheimer’s

Latest news

Off BACE: AZ/Lilly drop Alzheimer’s drug lanabecestat

s crenezumab and Roche/Chugai’s gantenerumab.
Glimmer of hope for amyloid drugs in Alzheimer's?

Roche also had updated results from a previously-reported trial of its gantenerumab candidate that failed to show a benefit on cognition.
Biogen Idec claims first with Alzheimer's candidate

That view took a knock last December however when Roche announced it was halting a phase III trial of its gantenerumab candidate in prodromal Alzheimer's after an independent panel concluded
AB Science on track for phase III data in Alzheimer's this year

of patients, with a host of failed projects including most recently Roche's gantenerumab.
Double trial disappointment for Roche

The Swiss pharma company will discontinue a phase III programme investigating its anti-amyloid medicine gantenerumab in people in the early stages of Alzheimer's after an analysis of interim data. ... Roche has not given up on gantenerumab completely,

More from news
Approximately 3 fully matching, plus 8 partially matching documents found.

Latest from PMHub

Alzheimer’s disease: reviewing the immediate treatment horizon

Crenezumab, gantenerumab, and solanezumab are all involved in additional prospective longitudinal investigations – the Alzheimer’ s Prevention Initiative (Phase 2), the Dominantly Inherited Alzheimer Network study (Phase 2/3), and the

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Senior Medical Writer (Remote Working): Competitive Salary Offered

Senior Account Managers - Oxfordshire: Attractive salary and benefits package offered

Associate Director: £75, 000-90, 000

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Medical Writers Required – Cheshire: DOE

Associate Director, Market Access & HEOR – North-West: Negotiable

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Account Director: Excellent benefits

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Digital Manager, London – Healthcare Brandcomms, Medcomms, PR: Excellent package

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Senior Account Manager- Central Oxford and Abingdon: Negotiable

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Freelance Account Manager / Senior Account Manager - Medical Edu...: £300 per day

Medical Writers: Competitive Salary and Benefits

SAM – Health Behaviour/ Patient Adherence Healthcare Agency: Salary TBC

Medical/ Scientific Director: Salary TBC

Medical Writer – Health Behaviour/ Patient Adherence Agency: Salary TBC

Events Manager – Med Comms – Surrey: Salary TBC

Account Director - Healthcare Advertising - London - HOME WORKIN...: £50000 - £68000

Production Manager – Healthcare Communications: DOE

Senior Medical Writer: Competitive Salary

Account Manager / Senior Account Manager: 35, 000-40, 000

Senior Medical Writer: Great salary and benefits

Associate Editorial Director – Med Comms – London: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...